Introduction
Influenza, commonly known as the flu, poses a significant health risk worldwide, particularly among children and adolescents. This age group not only suffers considerable illness and hospitalizations due to influenza but also plays a key role in transmitting the virus within communities. Vaccination remains the cornerstone of preventive strategies against influenza. Over the past two decades, two main types of influenza vaccines have been widely used among children and adolescents: Live Attenuated Influenza Vaccines (LAIV) and Inactivated Influenza Vaccines (IIV). A recent comprehensive review and meta-analysis spanning from 2003 to 2023 sheds light on how effective these vaccines are in the real world, helping parents, clinicians, and health professionals make informed decisions about flu prevention for young populations.
